BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36927647)

  • 1. Research progress of cathepsin B in brain aging and Alzheimer's diseases.
    Shang XK; Zhang SM; Ni JJ
    Yi Chuan; 2023 Mar; 45(3):212-220. PubMed ID: 36927647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Critical Role of Proteolytic Relay through Cathepsins B and E in the Phenotypic Change of Microglia/Macrophage.
    Ni J; Wu Z; Peterts C; Yamamoto K; Qing H; Nakanishi H
    J Neurosci; 2015 Sep; 35(36):12488-501. PubMed ID: 26354916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B plays a critical role in inducing Alzheimer's disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice.
    Wu Z; Ni J; Liu Y; Teeling JL; Takayama F; Collcutt A; Ibbett P; Nakanishi H
    Brain Behav Immun; 2017 Oct; 65():350-361. PubMed ID: 28610747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.
    Hook G; Yu J; Toneff T; Kindy M; Hook V
    J Alzheimers Dis; 2014; 41(1):129-49. PubMed ID: 24595198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.
    Mueller-Steiner S; Zhou Y; Arai H; Roberson ED; Sun B; Chen J; Wang X; Yu G; Esposito L; Mucke L; Gan L
    Neuron; 2006 Sep; 51(6):703-14. PubMed ID: 16982417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleus distribution of cathepsin B in senescent microglia promotes brain aging through degradation of sirtuins.
    Meng J; Liu Y; Xie Z; Qing H; Lei P; Ni J
    Neurobiol Aging; 2020 Dec; 96():255-266. PubMed ID: 33049518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways.
    Xie Z; Zhao M; Yan C; Kong W; Lan F; Narengaowa ; Zhao S; Yang Q; Bai Z; Qing H; Ni J
    Cell Death Dis; 2023 Apr; 14(4):255. PubMed ID: 37031185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer's disease pathogenesis.
    Yuyama K; Sun H; Fujii R; Hemmi I; Ueda K; Igeta Y
    Brain; 2024 Feb; 147(2):627-636. PubMed ID: 38071653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetrating Traumatic Brain Injury Triggers Dysregulation of Cathepsin B Protein Levels Independent of Cysteine Protease Activity in Brain and Cerebral Spinal Fluid.
    Boutté AM; Hook V; Thangavelu B; Sarkis GA; Abbatiello BN; Hook G; Jacobsen JS; Robertson CS; Gilsdorf J; Yang Z; Wang KKW; Shear DA
    J Neurotrauma; 2020 Jul; 37(13):1574-1586. PubMed ID: 31973644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extralysosomal cathepsin B in central nervous system: Mechanisms and therapeutic implications.
    Ni J; Lan F; Xu Y; Nakanishi H; Li X
    Brain Pathol; 2022 Sep; 32(5):e13071. PubMed ID: 35411983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders.
    Hook V; Yoon M; Mosier C; Ito G; Podvin S; Head BP; Rissman R; O'Donoghue AJ; Hook G
    Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140428. PubMed ID: 32305689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.
    Wang C; Sun B; Zhou Y; Grubb A; Gan L
    J Biol Chem; 2012 Nov; 287(47):39834-41. PubMed ID: 23024364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex.
    Viana GM; Gonzalez EA; Alvarez MMP; Cavalheiro RP; do Nascimento CC; Baldo G; D'Almeida V; de Lima MA; Pshezhetsky AV; Nader HB
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways.
    Farizatto KLG; Ikonne US; Almeida MF; Ferrari MFR; Bahr BA
    PLoS One; 2017; 12(8):e0182895. PubMed ID: 28797057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain.
    Sun L; Wu Z; Hayashi Y; Peters C; Tsuda M; Inoue K; Nakanishi H
    J Neurosci; 2012 Aug; 32(33):11330-42. PubMed ID: 22895716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression and altered subcellular distribution of cathepsin B in microglia induce cognitive impairment through oxidative stress and inflammatory response in mice.
    Ni J; Wu Z; Stoka V; Meng J; Hayashi Y; Peters C; Qing H; Turk V; Nakanishi H
    Aging Cell; 2019 Feb; 18(1):e12856. PubMed ID: 30575263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation.
    Perlenfein TJ; Murphy RM
    J Biol Chem; 2017 Dec; 292(51):21071-21082. PubMed ID: 29046353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behind every smile there's teeth: Cathepsin B's function in health and disease with a kidney view.
    Saudenova M; Promnitz J; Ohrenschall G; Himmerkus N; Böttner M; Kunke M; Bleich M; Theilig F
    Biochim Biophys Acta Mol Cell Res; 2022 Apr; 1869(4):119190. PubMed ID: 34968578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular cystatin SN and cathepsin B prevent cellular senescence by inhibiting abnormal glycogen accumulation.
    Oh SS; Park S; Lee KW; Madhi H; Park SG; Lee HG; Cho YY; Yoo J; Dong Kim K
    Cell Death Dis; 2017 Apr; 8(4):e2729. PubMed ID: 28383558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease.
    Nakamura Y; Takeda M; Suzuki H; Hattori H; Tada K; Hariguchi S; Hashimoto S; Nishimura T
    Neurosci Lett; 1991 Sep; 130(2):195-8. PubMed ID: 1795881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.